Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The aim of the Mashed Or Just Integral pill of TicagrelOr (MOJITO) study is to evaluate the
superiority of Ticagrelor 180 mg LD mashed pill versus Ticagrelor 180 mg LD integral pill
both orally administrated in decreasing residual platelet reactivity 1 hour after the
administration among 70 patients with STEMI (ST segment elevation myocardial infarction)
undergoing PPCI (primary percutaneous coronary intervention) with bivalirudin monotherapy.